Roger A’Hern
- Cancer Research top 0.1%
- Breast Cancer Treatment Studies 52
- Otorhinolaryngology top 0.1%
- Head and Neck Cancer Studies 21
- Oncology top 0.1%
- HER2/EGFR in Cancer Research 31
- Cancer survivorship and care 15
- Cancer Treatment and Pharmacology 15
- Reproductive Medicine top 0.2%
- Ovarian cancer diagnosis and treatment 24
- Pulmonary and Respiratory Medicine top 0.2%
-
- Estrogen and related hormone effects 36
-
- Breast Lesions and Carcinomas 17
Roger A’Hern
278 papers receiving 19.9k citations
Hit Papers
Peers
Comparison fields: 5 of 167
- Cancer Research 5.4k
- Otorhinolaryngology 1.5k
- Oncology 9.4k
- Reproductive Medicine 1.6k
- Pulmonary and Respiratory Medicine 5.2k
Countries citing papers authored by Roger A’Hern
This map shows the geographic impact of Roger A’Hern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger A’Hern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger A’Hern more than expected).
Fields of papers citing papers by Roger A’Hern
This network shows the impact of papers produced by Roger A’Hern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger A’Hern. The network helps show where Roger A’Hern may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Roger A’Hern, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2023 | 0 | |
| 3 | 2014 | 15 | |
| 4 | 2014 | 16 | |
| 5 | Intraoperative radiotherapy for breast cancer | 2014 | 3 |
| 6 | 2014 | 30 | |
| 7 | 2014 | 4 | |
| 8 | 2013 | 98 | |
| 9 | Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trialbreakdown → | 2011 | 1202 |
| 10 | 2010 | 14 | |
| 11 | 2010 | 75 | |
| 12 | Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Intervalbreakdown → | 2010 | 745 |
| 13 | 2009 | 1 | |
| 14 | 2003 | 1 | |
| 15 | Coordinate expression of apoptosis-associated proteins in human breast cancer before and during chemotherapy. | 2002 | 62 |
| 16 | Effects of the Aromatase Inhibitor Letrozole on Normal Breast Epithelial Cell Proliferation and Metabolic Indices in Postmenopausal Women | 2002 | 5 |
| 17 | 2001 | 6 | |
| 18 | 1998 | 63 | |
| 19 | 1989 | 152 | |
| 20 | 1984 | 4 |
About Roger A’Hern
Roger A’Hern is a scholar working on Oncology, Otorhinolaryngology and Cancer Research, having authored 282 papers that have together received 20.5k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (52 papers), Estrogen and related hormone effects (36 papers), HER2/EGFR in Cancer Research (31 papers), Ovarian cancer diagnosis and treatment (24 papers), Head and Neck Cancer Studies (21 papers), Breast Lesions and Carcinomas (17 papers), Cancer survivorship and care (15 papers) and Cancer Treatment and Pharmacology (15 papers). The work is most often cited by research in Cancer Research (5.4k citations), Otorhinolaryngology (1.5k citations) and Oncology (9.4k citations). Roger A’Hern has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Mitch Dowsett, Janine Salter, Martin Gore, Janet Hardy, Ian E. Smith, Cyril Fisher, Patrick Stone, Kevin J. Harrington, Joseph Thomas and Jorge S. Reis‐Filho. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Annals of Oncology, European Journal of Cancer and Radiotherapy and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.